ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.320
+0.270 (6.67%)
Mar 4, 2026, 1:20 PM EST - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $535.15 million as of March 4, 2026. Its market cap has increased by 245.92% in one year.
Market Cap
535.15M
Enterprise Value
724.40M
1-Year Change
245.92%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $535.15M, a decrease of -73.80%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 501.70M | 14.73% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forte Biosciences | 546.53M |
| Neumora Therapeutics | 543.80M |
| Rocket Pharmaceuticals | 539.59M |
| Altimmune | 520.96M |
| Lexeo Therapeutics | 520.40M |
| Fulcrum Therapeutics | 520.15M |
| Lyell Immunopharma | 511.98M |
| Zevra Therapeutics | 511.74M |